Vincristine and carboplatin chemotherapy for unresectable and/or recurrent low-grade astrocytoma of the brainstem

Pediatric Blood and Cancer

Volumn 55, Issue 3, 2010, Pages 471-477

  Ronghe, Milind ^a,b   Hargrave, Darren ^c   Bartels, Ute ^a   Tabori, Uri ^a   Vaidya, Sucheta ^c   Chandler, Chris ^c   Kulkarni, Abhaya ^a   Bouffet, Eric ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Brainstem glioma; Chemotherapy; Low grade glioma; Progressive; Recurrent; Unresectable

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; LOMUSTINE; PROCARBAZINE; TIOGUANINE; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ARTICLE; ASTROCYTOMA; BONE MARROW SUPPRESSION; BRAIN STEM; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CERVICAL SPINAL CORD; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; DETERIORATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; INOPERABLE CANCER; MALE; MEDULLA OBLONGATA; MESENCEPHALON; MULTIPLE CYCLE TREATMENT; PONS; PRIORITY JOURNAL; RECURRENT CANCER; RETROSPECTIVE STUDY; BRAIN STEM TUMOR; DISEASE COURSE; INFANT; PRESCHOOL CHILD; TUMOR RECURRENCE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASTROCYTOMA; BRAIN STEM; BRAIN STEM NEOPLASMS; CARBOPLATIN; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HUMANS; INFANT; MALE; NEOPLASM RECURRENCE, LOCAL; VINCRISTINE;

EID: 77955475099     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22557     Document Type: Article

References (28)

1. Rubin G, Michowitz S, Horev G, et al. Pediatric brain stem gliomas: An update. Childs Nerv Syst 1998;14:167-173.
2. Pollack IF, Hoffman HJ, Humphreys RP, et al. The long-term outcome after surgical treatment of dorsally exophytic brain-stem gliomas. J Neurosurg 1993;78:859-863.
3. Epstein F, Wisoff JH. Intrinsic brainstem tumors in childhood: Surgical indications. J Neurooncol 1988;6:309-317.
4. Pierre-Kahn A, Hirsch JF, Vinchon M, et al. Surgical management of brain-stem tumors in children: Results and statistical analysis of 75 cases. J Neurosurg 1993;79:845-852.
5. Weiner HL, Freed D, Woo HH, et al. Intra-axial tumors of the cervicomedullary junction: Surgical results and long-term outcome. Pediatr Neurosurg 1997;27:12-18.
6. Fisher BJ, Bauman GS, Leighton CE, et al. Low-grade gliomas in children: Tumor volume response to radiation. Neurosurg Focus 1998;4:e5.
7. West CG, Gattamaneni R, Blair V. Radiotherapy in the treatment of low-grade astrocytomas. I. A survival analysis. Childs Nerv Syst 1995;11:438-442.
8. Woo SY, Donaldson SS, Cox RS. Astrocytoma in children: 14 years' experience at Stanford University Medical Center. J Clin Oncol 1988;6:1001-1007.
9. Macdonald DR, Cascino TL, Schold SCJ, et al. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990;8:1277-1280.
10. Packer RJ, Ater J, Allen J, et al. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 1997;86:747-754.
11. Perilongo G, Walker DA, Taylor RE, et al. Vincristine (VCR) and carboplatin (CBDCA) in hypothalamic-chiasmatic low grade glioma (HG-LGG). SIOP-LGG study report. Med Pediatr Oncol 2000;35:190.
12. Broome CB, Schiff RI, Friedman HS. Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions. Med Pediatr Oncol 1995;26:105-110.
13. Khatib ZA, Heideman RL, Kovnar EH, et al. Predominance of pilocytic histology in dorsally exophytic brain stem tumors. Pediatr Neurosurg 1994;20:2-10.
14. Hoffman HJ, Soloniuk DS, Humphreys RP, et al. Management and outcome of low-grade astrocytomas of the midline in children: A retrospective review. Neurosurgery 1993;33:964-971.
15. Edwards MS, Wara WM, Ciricillo SF, et al. Focal brain-stem astro-cytomas causing symptoms of involvement of the facial nerve nucleus: Long-term survival in six pediatric cases. J Neurosurg 1994;80:20-25.
16. Freeman CR, Bourgouin PM, Sanford RA, et al. Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy. Clinical characteristics and treatment related toxicities. The Pediatric Oncology Group. Cancer 1996;77:555-562.
17. Duffner PK, Cohen ME, Thomas PR, et al. The long-term effects of cranial irradiation on the central nervous system. Cancer 1985;56:1841-1846.
18. Dirks PB, Jay V, Becker LE, et al. Development of anaplastic changes in low-grade astrocytomas of childhood. Neurosurgery 1994;34:68-78.
19. Bowers DC, Liu Y, Leisenring W, et al. Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: A report from the Childhood Cancer Survivor Study. J Clin Oncol 2006;24:5277-5282.
20. Castello MA, Schiavetti A, Padula A, et al. Does chemotherapy have a role in low-grade astrocytoma management? A report of 13 cases. Med Pediatr Oncol 1995;25:102-108.
21. Fouladi M, Hunt DL, Pollack IF, et al. Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945. Cancer 2003;98:1243-1252.
22. Rosenstock JG, Evans AE, Schut L. Response to vincristine of recurrent brain tumors in children. J Neurosurg 1976;45:135-140.
23. Zeltzer PM, Epport K, Nelson MD, Jr.,, et al. Prolonged response to carboplatin in an infant with brain stem glioma. Cancer 1991;67:43-47.
24. Kuo DJ, Weiner HL, Wisoff J, et al. Temozolomide is active in childhood, progressive, unresectable, low-grade gliomas. J Pediatr Hematol Oncol 2003;25:372-378.
25. Lafay-Cousin L, Sung L, Carret AS, et al. Carboplatin hypersensitivity reaction in pediatric patients with low-grade glioma: A Canadian Pediatric Brain Tumor Consortium experience. Cancer 2008;112:892-899.
26. Lafay-Cousin L, Holm S, Qaddoumi I, et al. Weekly vinblastine in pediatric low-grade glioma patients with carboplatin allergic reaction. Cancer 2005;103:2636-2642.
27. Ater J, Holmes E, Zhou T, et al. Results of COG protocol A9952: A randomized phase 3 study of two chemotherapy regimens for incompletely resected low-grade glioma in young children. Neuro-Oncology 2008;10:451.
28. Lefkowitz IB, Packer RJ, Sutton LN, et al. Results of the treatment of children with recurrent gliomas with lomustine and vincristine. Cancer 1988;61:896-902.